Paris-based ProductLife Group, a provider of regulatory, vigilance and quality services for the pharmaceutical, medtech and biotech sectors, announced that it has acquired Dutch-based Zwiers Regulatory Consultancy.
The Dutch company is a consultancy that specialises in regulatory affairs, pharmacovigilance, and integrated development for drugs and devices with offices in Amsterdam and Oss (Netherlands).
Providing full regulatory support
Founded in September 2011, Zwiers Regulatory Consultancy offers full regulatory support, throughout the entire drug lifecycle. From initial clinical trial application to post-marketing compliance.
In order to assure compliance throughout the product life cycle, it provides product development services in the EU, the US, and other countries. These services encompass early and late-stage strategic and regulatory assistance up to dossier submission and beyond. Its services include strategic advice, writing, creating, reviewing, and compiling regulatory and pharmacovigilance documents and eCTDs, as well as regulatory intelligence and training.
Rather than just performing tasks, the Zwiers team works proactively with the client to bring their business to the next level. Benefiting both patients and companies alike.
Aim of the acquisition
With this deal, ProductLife Group (PLG) broadens and improves its entire offering of services for drug development and medical device knowledge. The development of PLG’s footprint inside the Dutch life science ecosystem and its close proximity to the European Medicines Agency (EMA) will improve its capacity to provide its clients with worldwide assistance.
Zwiers Regulatory Consultancy says it has grown under the direction of founder and CEO Alex Zwiers by partnering with creative and innovative businesses and assisting them in choosing the best regulatory path for obtaining and maintaining registration.
Alex Zwiers says, “I see this as a very welcome partnership with us joining a large PLG family of like-minded people. Under the PLG brand, we can offer an even more complete package of high-quality services. Bundling our complementary activities with an organisation of excellent reputation like PLG, will enable us to extend our experience and creativity for the benefit of clients and their patients.”
Xavier Duburcq, CEO at PLG, adds, “This alliance will unlock meaningful potential and reinforce our ability to positively contribute to regulatory assessment, scientific progress, and the launch of successful treatments.”
Brief about ProductLife Group
The goal of PLG is to enhance human health by providing services and regulations that ensure the safe and efficient use of medical solutions. The company provides clients with support across the full product life cycle by fusing local knowledge with a worldwide network that spans more than 150 nations.
It also offers advisory and outsourced services in the fields of pharmaceutical development, regulatory affairs, quality control and compliance, vigilance, and medical information, including both well-known medicines and “cutting-edge” treatments & diagnostics.
PLG is dedicated to long-term partnerships, innovation, flexibility, and cost-effectiveness with the aim of continually enhancing the value provided to people and consumers.
